Lv1
30 积分 2021-04-19 加入
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
4天前
已完结
All That Is Small Is Not a Small-Cell Carcinoma: Thoracic SMARCA4-Deficient Undifferentiated Tumors Masquerading as SCLC
23天前
已完结
Advancements in small cell lung cancer
1个月前
已完结
Duodenal Follicular Lymphoma: Track or Treat?
1个月前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
5个月前
已关闭
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY
6个月前
已完结
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
6个月前
已完结
Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial
6个月前
已完结
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
1年前
已完结
High-dose chemotherapy for relapsed testicular germ cell tumours
1年前
已完结
皖公网安备34019202002308
